CADL Candel Therapeutics Inc

$CADL Anyone remember how CAPR went from $8 to $30+ upon and after filing their BLA ? Wouldn’t that be great? Our TAM and lung platform is far higher.

$CADL Since most people don’t look at responses I’m going to post my response here as well. I was treated with SBRT for prostate cancer in 2025. So I keep up with the latest developments, and the trend now is to minimize the use of ADT. There is a major study currently underway by Dr. Menard at the CHUM to see if metastasized prostate cancers in under five sites can be treated by SBRT without ADT. TELIX pharmaceuticals is advancing their AlphaPRO programme to develop an alpha-emitting radiopharmaceutical treatment for metastatic prostate cancer, using actinium-225 to deliver radiation to cancer cells expressing PSMA. This could signal a major shift away from ADT, possibly eliminating its need. 2409 can play a far bigger role in future cancer treatment then it’s phase 3 study undertook. They only have 2 other drugs in their pipeline and these drugs are related to 2409. So I don’t particularly see an overreach. Certainly nothing at this point that would warrant a drop in stock price.

$CADL Really thought i was done adding here like a month or two ago...If we drop below 8.00 I am absolutely increasing the position.

$CADL So many companies in last few months failing lung trials. Another one today - AVBP. Tough going at the moment, but we got the best MOS to speak of… Patience will pay off bigly here…

$CADL i al ready own 17,000 shares i hope it dips to the 7's i will probable add 23,000 more shares.

$CADL I can't say anything other than that this is a total mess. Congrats to the guys who sold in the 14 range —soon there'll be a perfect opportunity to buy back in. Personally, I just held on to my shares and bought more—maybe a little too soon, but I'm not worried.

$CADL I bought another 4000 shares this morning. Candel is a frustrating stock…. They announced great news —— no it was spectacular news—— from their trials and the stock goes down. I’ve seen similar news send other small biopharm stocks up into the 40s and 50s. But I’m going to keep believing and hoping the BLA submission … followed hopefully by approval…. Will finally send this stock much higher.

$CADL This is Candel compared to the BBC index for the past year. You can see how the index shorting took us down. Which means we will recover quickly.

$CADL this is one of the best biotechs on the market for future value. CEO is a genius. The science and delivery method together make this a winner. I love that its down $3-$4 bucks in the recent month or so. If this gets below 7, its a screaming buy.

$CADL l own a nice position in Palantir. $9 a couple of years ago to $200 today. I have been through a couple of 50% pullbacks thru that ride. It happens and for no reason at all. Palantir will go to$1k in a few years. I just have to be patient. I had to ignore stu back at the beginning, whom I might add trashed that as an overvalued pig when it was around$30. This is a winner, full stop! Take it from someone who has made multiple millions on a single stock. You will regret listening to that clown. Time will prove me correct.

$CADL You don’t get many opportunities in life like this one. Great trial results with durable efficacy making the drug a must have for patients. Results in hypofractionated that likely exceed surgery. SPA in place, with RMAT given after the P3 results. A virus vector that is super stable with stability being the last manufacturing hurdle. A CEO that is probably best in class for a bio under 1 billion in market cap. Inflation might print a bad number this morning but this is a 10B+ company. Good luck longs!

$CADL With this inflation tak is going to have to charge $210,000 per treatment instead of $200,000. Ok problem solved lets go back to $14

$CADL Good morning, everyone. There are 10 weeks left to go, and the BLA will be submitted in the meantime. Some dates will be announced before then. It’s shaping up to be an exciting few weeks leading up to the end of the year. Let’s see where things stand this week; it would be great if the share price were above 11 by then. Fingers crossed and good luck. 🤞🏻

$CADL I still have confidence in this stock, even though I'm currently sitting on a loss. Sending encouragement to myself and to all of you.

$CADL This is incrementally bullish for Candel because: 1. Aglatimagene’s NSCLC multi-omics work received conference-level recognition. 2. The analysis connects intratumoral and systemic immune activation with improved survival after checkpoint-inhibitor progression, according to the visible title. 3. The designation could draw more scientific and business-development attention to the poster.

$CADL Look @ those $10 Jan 2027 calls.....I wonder who in this world would be adding hundreds of those today :) Stay long my friends!!!

$CADL keep tucking those shares folks - my bet is we’ll be at new ATHs before year end - for those worried about a BLa Delay tak hasn’t let us down yet and believe he will deliver aces in December!

$CADL a market cap below 700 mil is a steal at this stage in the game. buy and hold this will turn around.

$CADL keep dca ing folks and block out the noise / new all time highs is my guess before eoy

$CADL 30-50% retracement in a biotech bull run are pretty ordinary moves, even within a wider uptrend. This is all part of the game.